Table 1.
Clinical and demographic characteristics of inpatients of pre-pandemic and post-pandemic seasons
|
2018–2019 (N = 300) |
2022–2023 (n = 294) |
P-value | |
|---|---|---|---|
| Male, N (%) | 146 (48.7) | 161 (54.8) | 0.137 |
| Age, Days (IQR) | 58.2 (37.5–100.6) | 65.1 (43.4–122.5) | 0.038 |
| Preterm Birth, N (%) | 33 (11.2) | 35 (11.7) | 0.867 |
| Palivizumab, N (%) | 4 (1.3) | 8 (2.7) | 0.256 |
| Birth Weight, Grams (IQR) | 3200 (2900–3550) | 3320 (2960–3580) | 0.086 |
| Breastfeeding, N (%) | 228 (76) | 227 (77.2) | 0.727 |
| Siblings, N (%) | 159 (76.4) | 190 (68.3) | 0.049 |
| Comorbidities | 12 (4.0) | 16 (5.5) | 0.397 |
| Los, days (IQR) | 5.9 (3.9–7.9) | 4.9 (3.0–6.9) | < 0.001 |
| Need For O2, N (%) | 206 (68.7) | 239 (81.3) | < 0.001 |
| LOO, Days (IQR) | 2.75 (0–5) | 3 (1–5) | 0.032 |
| Need for SOT, N (%) | 110 (36.7) | 136 (46.3) | 0.018 |
| SOT, Days (IQR) | 2 (1.25–3) | 2 (1–3) | 0.199 |
| Need for HFNC, N (%) | 121 (40.3) | 140 (47.6) | 0.074 |
| HFNC, Days (IQR) | 4 (3–5) | 3 (2–5) | 0.067 |
| Need for HCPAP, N (%) | 46 (15.3) | 52 (17.7) | 0.440 |
| HCPAP, Days (IQR) | 3 (2–5) | 3 (2–4) | 0.132 |
| Need for IMV, N (%) | 11 (3.7) | 8 (2.7) | 0.513 |
| IMV, Days (IQR) | 5 (4.5–8) | 4 (4–6) | 0.012 |
| RSV+ | 231 (77.0) | 205 (71.2) | 0.107 |
| Los, Days (IQR) | 5.9 (4.9–8.9) | 4.9 (3.9–6.9) | < 0.001 |
| Need for O2, N (%) | 179 (77.5) | 186 (90.1) | < 0.001 |
| Need for SOT, N (%) | 100 (43.3) | 106 (51.7) | 0.079 |
| Need for HFNC, N (%) | 104 (45.0) | 106 (51.7) | 0.163 |
| Need for HcPAP, N (%) | 45 (19.5) | 44 (21.5) | 0.608 |
| Need for IMV, N (%) | 11 (4.8) | 6 (2.9) | 0.323 |